| The N terminus of the adhesion G protein-coupled receptor GPR56 controls receptor signaling activity KJ Paavola, JR Stephenson, SL Ritter, SP Alter, RA Hall Journal of Biological Chemistry 286 (33), 28914-28921, 2011 | 201 | 2011 |
| Type IV collagen is an activating ligand for the adhesion G protein–coupled receptor GPR126 KJ Paavola, H Sidik, JB Zuchero, M Eckart, WS Talbot Science signaling 7 (338), ra76-ra76, 2014 | 195 | 2014 |
| Adhesion G protein-coupled receptors: signaling, pharmacology, and mechanisms of activation KJ Paavola, RA Hall Molecular pharmacology 82 (5), 777-783, 2012 | 147 | 2012 |
| Brain-specific angiogenesis inhibitor-1 signaling, regulation, and enrichment in the postsynaptic density JR Stephenson, KJ Paavola, SA Schaefer, B Kaur, EG Van Meir, RA Hall Journal of Biological Chemistry 288 (31), 22248-22256, 2013 | 112 | 2013 |
| Mutations of GPR126 are responsible for severe arthrogryposis multiplex congenita G Ravenscroft, F Nolent, S Rajagopalan, AM Meireles, KJ Paavola, ... The American Journal of Human Genetics 96 (6), 955-961, 2015 | 109 | 2015 |
| CCSP regulates cross talk between secretory cells and both ciliated cells and macrophages of the conducting airway SD Reynolds, PR Reynolds, JC Snyder, F Whyte, KJ Paavola, BR Stripp American Journal of Physiology-Lung Cellular and Molecular Physiology 293 (1 …, 2007 | 52 | 2007 |
| The fibronectin–ILT3 interaction functions as a stromal checkpoint that suppresses myeloid cells KJ Paavola, JM Roda, VY Lin, P Chen, KP O'Hollaren, R Ventura, ... Cancer immunology research 9 (11), 1283-1297, 2021 | 33 | 2021 |
| Apelin-36 modulates blood glucose and body weight independently of canonical APJ receptor signaling H Galon-Tilleman, H Yang, MA Bednarek, SM Spurlock, KJ Paavola, B Ko, ... Journal of Biological Chemistry 292 (5), 1925-1933, 2017 | 33 | 2017 |
| GLAST stability and activity are enhanced by interaction with the PDZ scaffold NHERF-2 SL Ritter, MJ Asay, M Paquet, KJ Paavola, RE Reiff, CC Yun, RA Hall Neuroscience letters 487 (1), 3-7, 2011 | 15 | 2011 |
| Abstract LB216: Pre-clinical characterization of NGM831, an ILT3 antagonist antibody for the treatment of solid tumors P Chen, SC Crawley, VY Lin, V Kapoor, KJ Paavola, HI Chen, ... Cancer Research 82 (12_Supplement), LB216-LB216, 2022 | 1 | 2022 |
| ILT2 and ILT4 drive myeloid suppression via both overlapping and distinct mechanisms J Tian, AM Ashique, S Weeks, T Lan, H Yang, HIH Chen, C Song, ... Cancer Immunology Research 12 (5), 592-613, 2024 | | 2024 |
| Ilt3-binding agents and methods of use thereof SC Crawley, JY Hsu, DD Kaplan, BC Li, VYB Lin, S Malmersjö, ... US Patent App. 18/364,285, 2024 | | 2024 |
| ILT3-binding agents and methods of use thereof SC Crawley, JY Hsu, DD Kaplan, BC Li, VYB Lin, S Malmersjö, ... US Patent 11,760,802, 2023 | | 2023 |
| Agentes de unión a ilt3 y métodos de uso de los mismos Y Wang, SC Crawley, JY Hsu, DD Kaplan, BC Li, VYB Lin, S Malmersjö, ... | | 2022 |
| Agentes de union a ilt3 y metodos de uso de los mismos SC Crawley, JY Hsu, DD Kaplan, BC Li, VYB Lin, S Malmersjo, ... | | 2022 |
| ilt3 binding factors and methods of their use SC Crawley, JY Hsu, DD Kaplan, BC Li, VYB Lin, KJ Paavola, JM Roda, ... | | 2022 |
| Ilt3-binding agents and methods of use thereof SC CRAWLEY, HSU Jer-Yuan, DD Kaplan, BC Li, VYB LIN, ... | | 2021 |
| APJ-independent Metabolic Actions of Apelin-36 H Galon-Tilleman, H Yang, MA Bednarek, SM Spurlock, KJ Paavola, B Ko, ... | | 2016 |
| Autosomal recessive mutations of GPR126 are responsible for severe arthrogryposis multiplex congenita G Ravenscroft, F Nolent, S Rajagopalan, A Meireles, K Paavola, ... Neuromuscular Disorders 25, S186, 2015 | | 2015 |
| BRAIN-SPECIFIC ANGIOGENESIS INHIBITOR-1 SIGNALING VIA G alpha (12/13) TO RHO, REGULATION BY PDZ SCAFFOLDS AND ENRICHMENT IN THE POSTSYNAPTIC DENSITY JR Stephenson, KJ Paavola, SA Schaefer, B Kaur, EG Van Meir, RA Hall JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION 33 (3), 203-203, 2013 | | 2013 |
